Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This is an open label, single-center study to determine the absolute bioavailability and
nasopharyngeal absorption of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.